John A. Gruner

Corporate Officer/Principal bei Melior Discovery, Inc.

Consumer Services

Commercial Services

Health Technology

Profil

John A.
Gruner is currently the Neurophysiology Director at Melior Discovery, Inc. He was previously a Principal at Cephalon, Inc. Gruner holds a doctorate from Purdue University and an undergraduate degree from the University of California San Diego.

Aktive Positionen von John A. Gruner

Unternehmen	Position	Beginn
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Corporate Officer/Principal	-

Alle aktiven Positionen von John A. Gruner

Ehemalige bekannte Positionen von John A. Gruner

Unternehmen	Position	Ende
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von John A. Gruner im Detail an

Ausbildung von John A. Gruner

Purdue University	Doctorate Degree
University of California San Diego	Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von John A. Gruner im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Commercial Services
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Health Technology